Skip to main content

Table 2 Qualitiy of life score (mean) during intravenous TRD-treatment

From: Prevention of disease progression in a patient with a gastric cancer-re-recurrence. Outcome after intravenous treatment with the novel antineoplastic agent taurolidine. Report of a case

  Day 1 Day 5
Physical 10.6 10.7
Emotional 4.1 4.0
Social 3.0 3.0
Fatigue 12.2 11.8
Pain 1.0 1.0
Dyspnea 2.1 2.2
Global quality of life 9.0 9.1